Investigational drug · Phase 2
NCR100
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Knee Osteoarthritis.
Phase 2Last checked: Nov 19, 2026Latest source record: Dec 18, 2024 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
3
Any phase or sponsor naming "NCR100"
First trial start
2025
Feb 20, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "NCR100", any sponsor or status.
Conditions studied
As listed on its trial records.
- Knee Osteoarthritis
Approved drugs for the same conditions: Osteoarthritis
Largest trials
Live from ClinicalTrials.gov: studies naming "NCR100" as an intervention, largest first.
- A Study of NCR100 Injection for the Treatment of Knee Osteoarthritis( KOA)Pivotal-lookingNot yet recruiting
Nuwacell Biotechnologies Co., Ltd.Industry
NCT06741098 · 162 participants (planned) · Start Feb 20, 2025 · Primary completion Nov 30, 2026
Drug: NCR100 · For: Knee Osteoarthritis
- A Trial to Evaluate the Safety, Tolerability, and Efficacy of NCR100 Injection in the Treatment of Subjects With KOAStatus unknown
Nuwacell Biotechnologies Co., Ltd.Industry
NCT06049342 · 12 participants (planned) · Start Jan 25, 2024 · Primary completion Jun 2024
Drug: NCR100 injection · For: Knee Osteoarthritis
- A Study of [89Zr]-Oxine-NCR100 Injection for the Cellular DistributionNot yet recruiting
Nuwacell Biotechnologies Co., Ltd.Industry
NCT07139431 · 6 participants (planned) · Start Aug 29, 2025 · Primary completion Mar 6, 2026
Drug: NCR100 · For: KOA
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Knee Osteoarthritis
- EcnoglutideXW003, VRB-101Phase 38 trials
Hangzhou Sciwind Biosciences Co., Ltd. · Obesity, Weight Management, OSA - Obstructive Sleep Apnea
- hUC-MSCsmesenchymal stem cells, MSCPhase 38 trials
Shenzhen Wingor Biotechnology Co., Ltd. · Knee Osteoarthritis, Crohn&Amp;#39;s, Crohn&Amp;#39;s Disease (CD)
- JOINTSTEMPhase 32 trials
R-Bio · Knee Osteoarthritis, Osteoarthritis, Knee
- Reference DrugNSAIDsPhase 32 trials
SANGMYUNG innovation · Retinal Vein Occlusion With Macular Edema, Knee Osteoarthritis
- PTP-01MOTYS, allogeneic human placental tissue particulatePhase 31 trial
Doron Therapeutics Inc. · Knee Osteoarthritis
- Human umbilical cord blood-derived mesenchymal stem cellsSMUP-IA-01, mid-dosePhase 22 trials
Medipost Co Ltd. · Knee Osteoarthritis, Bronchopulmonary Dysplasia, BPD
- TTAX03Phase 22 trials
BioTissue Holdings, Inc · Knee Osteoarthritis, Knee Pain Chronic, Knee Arthritis
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.